Loading market dashboard
Bioventus Inc.
BVSHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Bioventus Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $793.38M | $787.22M - $801.03M | $12.26M | $1.23 | 1 |
| Dec 2029 | $737.13M | $731.40M - $744.23M | $11.39M | $1.07 | 2 |
| Dec 2028 | $685.27M | $685.27M - $685.27M | $10.59M | $1.07 | 3 |
| Dec 2027 | $645.45M | $636.81M - $654.09M | $9.98M | $0.906 | 4 |
| Dec 2026 | $605.30M | $603.38M - $607.21M | $9.36M | $0.776 | 4 |
| Dec 2025 | $565.88M | $561.49M - $571.34M | $8.75M | $0.661 | 2 |
| Dec 2024 | $564.94M | $560.56M - $570.39M | $8.73M | $0.402 | 2 |
| Dec 2023 | $536.89M | $532.72M - $542.07M | $8.30M | -$0.662 | 1 |
| Dec 2022 | $521.72M | $516.17M - $527.27M | $6.32M | $0.258 | 1 |
| Dec 2021 | $430.39M | $428.28M - $432.66M | $5.21M | $0.901 | 1 |
| Dec 2020 | $320.87M | $319.30M - $322.56M | $3.89M | $0.86 | 1 |